Srinivas Rao

Chief Scientific Officer at CYPRESS BIOSCIENCE INC · on record since Nov 1, 2007
SVP and Chief Medical Officer at Assertio Therapeutics, Inc · on record since Feb 6, 2015

Insider trading activity of Srinivas Rao

Transactions on record: 20; since Jan 4, 2008

Open-market buys: 0

Open-market sells: 1; $48.3K

Companies traded: 2; last filing Apr 4, 2017

Figures computed from official regulatory filings — .

Companies where Srinivas Rao has traded

Assertio Therapeutics, Inc14 tx · $175.5K · Apr 4, 2017
CYPRESS BIOSCIENCE INC6 tx · $83.9K · Dec 21, 2010

Track record of Srinivas Rao

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Srinivas Rao

Co-insiders of Srinivas Rao

ANDERSON SAMUELCYPRESS BIOSCIENCE INC
ANIDO VICENTE JRAssertio Therapeutics, Inc
BERNER BRETAssertio Therapeutics, Inc
BIOVAIL LABORATORIES INCAssertio Therapeutics, Inc
Bukofzer StanAssertio Therapeutics, Inc
BURRILL STEVENAssertio Therapeutics, Inc
CALLAGHAN MICHAEL JAssertio Therapeutics, Inc
Cameron TammyAssertio Therapeutics, Inc
DAWES KAREN AAssertio Therapeutics, Inc
DONENBERG PHILIP BAssertio Therapeutics, Inc
EDELMAN JOSEPHCYPRESS BIOSCIENCE INC
FARA JOHN WAssertio Therapeutics, Inc
FOGARTY JAMES PAssertio Therapeutics, Inc
GENDREAU R MICHAELCYPRESS BIOSCIENCE INC
Gosling Matthew MAssertio Therapeutics, Inc
HAMILTON JOHN FAssertio Therapeutics, Inc
HAWLEY ROGERCYPRESS BIOSCIENCE INC
HIGGINS ARTHUR JAssertio Therapeutics, Inc
JOHNSON SABRINA MARTUCCICYPRESS BIOSCIENCE INC
Kalali Amir HCYPRESS BIOSCIENCE INC
KELLER MARTINCYPRESS BIOSCIENCE INC
KESSEL LARRYCYPRESS BIOSCIENCE INC
KRANZLER JAY DCYPRESS BIOSCIENCE INC
LAVIGNE LOUIS J JRAssertio Therapeutics, Inc
MCGARITY JON WCYPRESS BIOSCIENCE INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Assertio Therapeutics, IncSecurity delisted	Apr 4, 2017	Other	-940	12.55 USD	$11.8K	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 10, 2017	AwardD (derivative)	29,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 10, 2017	AwardD (derivative)	66,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Dec 6, 2016	Other	-4,793	18.55 USD	$88.9K	SEC
Assertio Therapeutics, IncSecurity delisted	Apr 5, 2016	Other	-940	14.38 USD	$13.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Mar 9, 2016	ExerciseD (derivative)	-2,535	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Mar 9, 2016	Exercise	2,535	11.83 USD	$30K	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 16, 2016	AwardD (derivative)	82,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 16, 2016	AwardD (derivative)	33,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Dec 3, 2015	Other	-1,645	19.00 USD	$31.3K	SEC
Assertio Therapeutics, IncSecurity delisted	May 14, 2015	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 6, 2015	AwardD (derivative)	32,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 6, 2015	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jul 18, 2014	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Dec 21, 2010	ExerciseD (derivative)	-7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Dec 21, 2010	Exercise	7,500	4.75 USD	$35.6K	SEC
CYPRESS BIOSCIENCE INCListing unverified	Dec 21, 2010	Sell	-7,500	6.44 USD	$48.3K	SEC
CYPRESS BIOSCIENCE INCListing unverified	Jan 6, 2010	AwardD (derivative)	27,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Jan 7, 2009	AwardD (derivative)	90,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Jan 4, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Assertio Therapeutics, IncSecurity delisted	Apr 4, 2017	Other	-940	12.55 USD	$11.8K	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 10, 2017	AwardD (derivative)	29,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 10, 2017	AwardD (derivative)	66,400	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Dec 6, 2016	Other	-4,793	18.55 USD	$88.9K	SEC
Assertio Therapeutics, IncSecurity delisted	Apr 5, 2016	Other	-940	14.38 USD	$13.5K	SEC
Assertio Therapeutics, IncSecurity delisted	Mar 9, 2016	ExerciseD (derivative)	-2,535	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Mar 9, 2016	Exercise	2,535	11.83 USD	$30K	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 16, 2016	AwardD (derivative)	82,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 16, 2016	AwardD (derivative)	33,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Dec 3, 2015	Other	-1,645	19.00 USD	$31.3K	SEC
Assertio Therapeutics, IncSecurity delisted	May 14, 2015	AwardD (derivative)	5,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 6, 2015	AwardD (derivative)	32,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Feb 6, 2015	AwardD (derivative)	17,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
Assertio Therapeutics, IncSecurity delisted	Jul 18, 2014	AwardD (derivative)	150,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Dec 21, 2010	ExerciseD (derivative)	-7,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Dec 21, 2010	Exercise	7,500	4.75 USD	$35.6K	SEC
CYPRESS BIOSCIENCE INCListing unverified	Dec 21, 2010	Sell	-7,500	6.44 USD	$48.3K	SEC
CYPRESS BIOSCIENCE INCListing unverified	Jan 6, 2010	AwardD (derivative)	27,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Jan 7, 2009	AwardD (derivative)	90,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
CYPRESS BIOSCIENCE INCListing unverified	Jan 4, 2008	AwardD (derivative)	50,000	0.00	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC